Kristin Yarema
CEO & DirectorDr. Kristin Yarema, Ph.D., serves as the Chief Executive Officer and Director at ImageneBio, Inc. since July 2025 and was its Interim Principal Financial Officer from October 21, 2025 to July 20, 2026. Dr. Yarema served as President & CEO of Poseida Therapeutics, Inc. since January 01, 2024 and served as its Director since January 2024. She was the Chief Commercial Officer and Senior Vice President of Atara Biotherapeutics, Inc. from February 18, 2020, until November 15, 2022. She has biopharmaceutical experience during which she has led product strategy and commercialization for therapies at all stages of their life cycle, including those newly entering clinical development, products undergoing multi-region global launches and maturing products seeking continued growth. She served as Amgen’s Vice President & Therapeutic Area Head for Global Product Strategy & Commercial Innovation in Hematology and Oncology. In this role, she had global accountability for all marketed and pipeline products, including a portfolio of innovative therapies for various hematological malignancies such as multiple myeloma, leukemia and lymphoma. During her seven years at Amgen, Dr. Yarema also served in multiple U.S. commercial roles and as global therapeutic area head for other assets within Amgen’s portfolio, including those in neuroscience and autoimmune diseases; she also initiated programs in rare and orphan diseases. From July 2007 to January 2013, she held numerous roles of increasing responsibility at Novartis AG. From September 2000 to June 2007, she held roles of increasing responsibility at McKinsey & Company. Dr. Yarema earned a Ph.D. in Biochemical Engineering from the University of California, Berkeley and attended Stanford University, where she earned a B.S. in Chemical Engineering with Distinction and a B.A. in English with Distinction. In addition, she has served on the Board of Directors for the Celiac Disease Foundation, a U.S.-based patient advocacy group, since 2017 and as a board member of the Alliance for Regenerative Medicine, an international patient advocacy organization dedicated to realizing the promise of regenerative medicines and therapies, since 2020.
Positions
- Company NameImageneBio, Inc.Stock CodeIMAPositionCEO & DirectorColleagues
- JJJonathan Jian WangChairman
- YGYanina Grant-HuertaCFO, Principal Financial Officer & Principal Accounting Officer
- KPKurinji PandiyanChief Strategy & Operations Officer
- RSRenuka SivendranChief Technical Officer
- MRMatt RobbinsGeneral Counsel
- DBDavid BonitaLead Independent Director
- OSOtello StampacchiaIndependent Director
- JPJoseph P. SlatteryDirector
